Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

The chemo causes indiscriminate DNA damage across

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155130
(Total Views: 410)
Posted On: 07/13/2025 4:08:26 PM
Posted By: ohm20
Re: Katangolo #155093
Quote:
The chemo causes indiscriminate DNA damage across all cell types be cancer or healthy cells and that’s why the body needs a break to repair the DNA. If I’m thinking right and I think you might’ve mentioned this before the expression of PDL one on cancer cells allow them to be more effectively. Targeted by chemotherapy and healthy cells are not affected nearly as much by the chemo. Do I have that right? And DNA repair happens much faster and healthy cells after being given LL. I assume this would be the same for BPG drug correct?



Chemotherapy will damage healthy cells and tumor cells. Newer chemotherapy uses markers that are expressed on tumor cells to target just the tumor with much less damage to normal cells. PD-L1 would probably not be optimal for targeted chemotherapy because of expression of PD-L1 on normal cells. PD-L1 is targeted by anti-PD-L1 ICIs not chemotherapy. DNA repair doesn't happen much faster with leronlimab. If that was the case then tumor cells would survive.

Leronlimab stops the tumor cell DNA from repairing via PI3K/AKT/ELF4E inhibition causing tumor cells to die. The BPG drug does not affect DNA repair directly.


(11)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us